| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |